Januszewski Adam - Barts Health NHS Trust

基本信息

浏览量：3

职业迁徙

个人简介

暂无内容

研究兴趣

论文共 50 篇作者统计合作学者相似作者

按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选

263 the Use of 3,4-Diaminopyridine (3,4-DAP) in the Management of Life-Threatening Paraneoplastic Lambert Easton Myasthenic Syndrome (LEMS) – A Case Report

Kennedy Louis, Westerman Tanith,Kolotia Balwinder, Gorgoraptis Nikolaos,Januszewski Adam

Lung Cancer (2025): 108372

引用0浏览0引用

112 Real-World Outcomes in Patients Treated with First-line Anti-PD(L)-1 Immune Checkpoint Inhibitors for Non-Small Cell Lung Cancer - A Single Tertiary Centre Experience

Patel Radhika, Alam Akashi, Westerman Tanith, Lalwani Salina,Januszewski Adam,So Alfred

Lung Cancer (2025): 108222

引用0浏览0引用

19 the Development of a Patient Engagement Intervention to Improve Lung Cancer Patients’ and Carers’ Experience of and Engagement in Their Recommended Lung Cancer Care Pathway in Rural, Coastal, and Urban Settings

Cooke Samuel,Mitchinson Lucy,Quaife Samantha,Ricketts William,Januszewski Adam,Lerner Anna,Pogson Zara,Skinner Dawn,Civello Sarah,Kane Ros,Harding-Bell Ava,Calman Lynn,Selby Peter,Peake Michael, Waller Jo,Nelson David,McInnerney Daisy

Lung Cancer (2025): 108130

引用0浏览0引用

258 HORIZON-01: a Phase I–III Platform Study Evaluating the Efficacy and Safety of Multiple Therapies in Patients with Biomarker-Defined Locally Advanced, Unresectable Stage III Non-Small Cell Lung Cancer (NSCLC)

Popat Sanjay,Januszewski Adam,Cove-Smith Laura,Baijal Shobhit, Imseeh Georgios, Gay Carl,Kerr Keith,Kato Terufumi,Paz-Ares Luis,Zhou Caicun, Redhead Karl, Theogaraj Elizabeth, Shagan Sarah M.,Solomon Benjamin J.

Lung Cancer (2025): 108367

引用0浏览0引用

125 Evaluation of Patients Experience of Receiving Immunotherapy (IO)

Smith Bing,Januszewski Adam, Leggett John,Reeves Annie,Kolotia Balwinder, Connolly Karen

Lung Cancer (2025): 108235

引用0浏览0引用

92 Clinical Impact and Real-World UK Multi-Center Experience of Neoadjuvant Chemoimmunotherapy for Resectable NSCLC

Milic Marina, Cheung Maggie, Bolnykh Lakov,Newsom-Davis Thomas,Januszewski Adam,Ahmad Tanya,Papadatos-Pastos Dionysis,Lee Siow Ming, Jamal-Hanjani Mariam,Forster Martin,Benafif Sarah

Lung Cancer (2025): 108202

引用0浏览0引用

98 Hospitalisation Rates Following Systemic Anti-Cancer Treatments for Patients with Non-Small Cell Lung Cancer

Chambers Pinkie, Almossawi Ofran,Steventon Luke,Wei Li, Wang Zhe,Dodwell David, Man Kenneth,Januszewski Adam, Giddings Rebecca,Forster Martin

Lung Cancer (2025): 108208

引用0浏览0引用

Long Term Efficacy of First-Line Afatinib and the Clinical Utility of Ctdna Monitoring in Patients with Suspected or Confirmed EGFR Mutant Non-Small Cell Lung Cancer Who Were Unsuitable for Chemotherapy

Sanjay Popat,Adam Januszewski,Mary O’Brien,Tanya Ahmad,Conrad Lewanski, Ulrike Dernedde,Petra Jankowska,Clive Mulatero,Riyaz Shah, Jonathan Hicks,Tom Geldart,Mathilda Cominos,Gill Gray,James Spicer,Karen Bell, Simon Roitt,Clive Morris,Yenting Ngai,Laura Hughes,Allan Hackshaw,William Wilson

British journal of cancerno. 3 (2024): 245-252

引用0浏览0WOSNATURE引用

Can Simulation Be an Effective Means of Preparing Trainees for Active Participation in MDT Meetings?: A Quality Improvement Project

Ewan Mackay, K. Patel, Davidson Colette,Jessica Little,Karen Tipples,Adam Januszewski,William Ricketts

Future Healthcare Journalpp.100017-100017, (2024)

引用0浏览0引用

101 Real-world Analysis of the Impact of Pemetrexed in First-Line Maintenance (1LM) with Immunotherapy (IO) for Non-Squamous (NSQ) Advanced/metastatic Non-Small Cell Lung Cancer (a/mnsclc) Lacking Targetable Mutations, Prior to and During the COVID-19 Pandemic

Fabio Gomes,Niall Gilding,Vivian Tan, Katerina Christoforou, Joanne Rule,Amine Aziez,Adam Januszewski,Anna Minchom

Lung Cancer (2024): 107662

引用0浏览0引用

加载更多

作者统计

合作学者

合作机构

D-Core

合作者
学生
导师

暂无相似学者，你可以通过学者研究领域进行搜索筛选

数据免责声明

页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果，我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问，可以通过电子邮件方式联系我们：report@aminer.cn